AFFiRiS logo_white with blue globe.PNG
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
July 27, 2021 08:00 ET | AFFiRiS AG
AFFiRiS to receive AC Immune stock valued at USD 58.7 million in exchange for its portfolio of therapeutics targeting alpha-synuclein and USD 5 million in cashAFFiRiS to focus on partnering to further...
AFFiRiS logo_white with blue globe.PNG
Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17 to treat Huntington’s disease to be presented at the 16th Annual Huntington's Disease Therapeutics Conference
April 27, 2021 03:00 ET | AFFiRiS AG
Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of Huntington’s disease pathologyHuman mtHTT transgenic mice treated with mAB C6-17 showed...
TCF FINANCIAL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of TCF and Encourages Investors to Contact the Firm
December 16, 2020 12:07 ET | Bragar Eagel & Squire
NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of TCF...
Meritex Announces Sale of Office/Warehouse Building in Savage, Minnesota
October 07, 2014 03:00 ET | Meritex Enterprises
MINNEAPOLIS, MN--(Marketwired - October 07, 2014) - Meritex announced today the sale of 14399 Huntington Avenue in Savage, Minnesota. The property totals 244,050 SF and is 100% leased to two tenants:...